KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Gilead Sciences (GILD) Shares Issued (2016 - 2025)

Historic Shares Issued for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $97.0 million.

  • Gilead Sciences' Shares Issued fell 102.04% to $97.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $549.0 million, marking a year-over-year increase of 9963.64%. This contributed to the annual value of $422.0 million for FY2024, which is 8189.66% up from last year.
  • Gilead Sciences' Shares Issued amounted to $97.0 million in Q3 2025, which was down 102.04% from $27.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Shares Issued ranged from a high of $252.0 million in Q1 2025 and a low of $3.0 million during Q2 2022
  • Moreover, its 5-year median value for Shares Issued was $83.0 million (2023), whereas its average is $79.4 million.
  • In the last 5 years, Gilead Sciences' Shares Issued surged by 136666.67% in 2022 and then tumbled by 8522.73% in 2023.
  • Gilead Sciences' Shares Issued (Quarter) stood at $12.0 million in 2021, then soared by 1366.67% to $176.0 million in 2022, then plummeted by 85.23% to $26.0 million in 2023, then skyrocketed by 565.38% to $173.0 million in 2024, then plummeted by 43.93% to $97.0 million in 2025.
  • Its last three reported values are $97.0 million in Q3 2025, $27.0 million for Q2 2025, and $252.0 million during Q1 2025.